Mr. Mark F Sheridan, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: #3 Stonecrest Dr, Huntington, WV 25701 Phone: 304-522-6388 Fax: 304-522-8040 |
Dr. Stephen K Wolfe, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1540 Spring Valley Dr, Huntington, WV 25704 Phone: 304-429-6741 |
Mr. George Stephen Dawson Ii, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5170 Us Rt 60 East, Huntington, WV 25705 Phone: 304-528-4600 Fax: 304-399-2272 |
Joseph B Touma, MD Otolaryngology - Otology & Neurotology Medicare: Not Enrolled in Medicare Practice Location: 1616 13th Ave, Suite 100, Huntington, WV 25701 Phone: 304-522-8800 Fax: 304-523-4303 |
Mr. Phillip R Stevens, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: #3 Stonecrest Drive, Huntington, WV 25701 Phone: 304-522-6388 Fax: 304-522-8040 |
Scott R Gibbs, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1600 Medical Center Dr, Suite 2500, Huntington, WV 25701 Phone: 304-691-1200 Fax: 304-691-1287 |
Dr. Thomas M Jung, MD PHD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: #3 Stonecrest Dr, Huntington, WV 25701 Phone: 304-522-6388 Fax: 304-522-8040 |
B Joseph Touma, MD Otolaryngology - Otology & Neurotology Medicare: Accepting Medicare Assignments Practice Location: 5170 Us Rt 60 East, Suite 100, Huntington, WV 25705 Phone: 304-528-4600 |
News Archive
Wounds suffered by patients with diabetes tend to heal poorly. For treatment to work, the patient's physician must discuss the situation with specialists and nursing staff to decide on the best approach. However, e-mailing the files containing the diagnosis and discussing them on the telephone is a time-consuming process.
Scientists in China are reporting discovery of two proteins present in the blood of people with colon cancer that may serve as the potential biomarkers for accurately predicting whether the disease will spread. Their study is in ACS' Journal of Proteome Research, a monthly publication.
More than a cancer-causing gene is needed to trigger pancreatic cancer, a study led by Mayo Clinic has found. A second factor creates a "perfect storm" that allows tumors to form, the researchers say. The study, published in the Sept. 10 issue of Cancer Cell, overturns the current belief that a mutation in the KRAS oncogene is enough to initiate pancreatic cancer and unrestrained cell growth.
Carl Zeiss Meditec AG and Oraya Therapeutics, Inc. jointly announced today that the companies have entered into a collaboration agreement under which Carl Zeiss Meditec will provide funding to Oraya over a period of up to two years for the implementation of Oraya's growth strategy, and in turn receive rights in the company reaching up to a majority stake after two years.
› Verified 1 days ago